Wang, Z.; Wu, J.; Meng, X.; Weng, H.; Li, Q.; Li, L.; Ma, Z.; Bi, S.; Han, Q.; Zhao, H.;
et al. A CpG 1018S/QS-21-Adjuvanted HBsAg Therapeutic Vaccine as a Novel Strategy Against HBV. Vaccines 2025, 13, 1014.
https://doi.org/10.3390/vaccines13101014
AMA Style
Wang Z, Wu J, Meng X, Weng H, Li Q, Li L, Ma Z, Bi S, Han Q, Zhao H,
et al. A CpG 1018S/QS-21-Adjuvanted HBsAg Therapeutic Vaccine as a Novel Strategy Against HBV. Vaccines. 2025; 13(10):1014.
https://doi.org/10.3390/vaccines13101014
Chicago/Turabian Style
Wang, Zixuan, Jing Wu, Xiaohan Meng, He Weng, Qiang Li, Lin Li, Zhenhao Ma, Sirong Bi, Qiuju Han, Huajun Zhao,
and et al. 2025. "A CpG 1018S/QS-21-Adjuvanted HBsAg Therapeutic Vaccine as a Novel Strategy Against HBV" Vaccines 13, no. 10: 1014.
https://doi.org/10.3390/vaccines13101014
APA Style
Wang, Z., Wu, J., Meng, X., Weng, H., Li, Q., Li, L., Ma, Z., Bi, S., Han, Q., Zhao, H., Liu, C., & Meng, D.
(2025). A CpG 1018S/QS-21-Adjuvanted HBsAg Therapeutic Vaccine as a Novel Strategy Against HBV. Vaccines, 13(10), 1014.
https://doi.org/10.3390/vaccines13101014
